Preparation of embolic NEMs loading capecitabineYUANGANG LIU; PENG HE; SHIBIN WANG et al.Journal of materials science. Materials in medicine. 2013, Vol 24, Num 1, pp 155-160, issn 0957-4530, 6 p.Article

Disparition de kératoses actiniques avec la capécitabine = Resolution of actinic keratosis with capecetabinSCHMUTZ, J.-L; TRECHOT, P.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 11, pp 759-760, issn 0151-9638, 2 p.Article

Case 1. Pseudomyxoma peritonei: Response to capecitabineLEVITZ, Jason S; SUGARBAKER, Paul H; LICHTMAN, Stuart M et al.Journal of clinical oncology. 2004, Vol 22, Num 8, pp 1518-1520, issn 0732-183X, 3 p.Article

Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulationMILANO, G; FERRERO, J.-M; FRANCOIS, E et al.British journal of cancer. 2004, Vol 91, Num 4, pp 613-617, issn 0007-0920, 5 p.Article

Capecitabine- induced multifocal leukoencephalopathy : A report of five casesVIDENOVIC, A; SEMENOV, I; RAIZER, J. J et al.Neurology. 2005, Vol 65, Num 11, pp 1792-1794, issn 0028-3878, 3 p.Article

Genital Erythrodysesthesia as a Severe Manifestation of Capecitabine Therapy: A Report of 3 CasesFLETA-ASIN, Beatriz; ALCANTARA-GONZALEZ, Javier; ALONSO-CASTRO, Leticia et al.Archives of dermatology (1960). 2011, Vol 147, Num 9, pp 1123-1124, issn 0003-987X, 2 p.Article

Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancerSOUGLAKOS, John; ANDROULAKIS, Nikolaos; GEORGOULIAS, Vassilios et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 5, pp 1284-1287, issn 0360-3016, 4 p.Article

Resolving actinic keratoses: an expected side-effect of capecitabine therapyAL-NIAIMI, F; LYON, C.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 1, pp 68-69, issn 0307-6938, 2 p.Article

Capecitabine-Induced Chest Pain Relieved by DiltiazemAMBROSY, Andrew P; KUNZ, Pamela L; FISHER, George A et al.The American journal of cardiology. 2012, Vol 110, Num 11, pp 1623-1626, issn 0002-9149, 4 p.Article

Capecitabine-induced coronary vasospasm: A case reportRIZVI, Asad A; SCHAUER, Peter; OWLIA, Dariush et al.Angiology. 2004, Vol 55, Num 1, pp 93-97, issn 0003-3197, 5 p.Article

Hand-Fuß-syndrom bei einem Patienten unter Capecitabin-Therapie = Hand-foot syndrome with capecitabine therapyMARINI, A; HENGGE, U. R.Hautarzt. 2007, Vol 58, Num 6, pp 532-536, issn 0017-8470, 5 p.Article

Toxic encephalopathy induced by capecitabineNIEMANN, B; ROCHLITZ, C; HERRMANN, R et al.Oncology. 2004, Vol 66, Num 4, pp 331-335, issn 0030-2414, 5 p.Article

Optimizing Chemotherapy Dose and Schedule by Norton-Simon Mathematical ModelingTRAINA, Tiffany A; DUGAN, Ute; HIGGINS, Brian et al.Breast disease. 2010, Vol 31, Num 1, pp 7-18, issn 0888-6008, 12 p.Article

Hiperpigmentación secundaria a capecitabina = Capecitabine induced hyperpigmentationVAZQUEZ-BAYO, C; RODRIGUEZ-BUJALDON, A. L; JIMENEZ-PUYA, R et al.Actas dermo-sifiliográficas (Ed. impresa). 2007, Vol 98, Num 7, pp 491-493, issn 0001-7310, 3 p.Article

The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective studyMICHIE, C. O; SAKALA, M; RIVANS, I et al.British journal of cancer. 2010, Vol 103, Num 5, pp 617-621, issn 0007-0920, 5 p.Article

Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR)EBI, Hiromichi; SIGEOKA, Yasushi; SAEKI, Toshiaki et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 2, pp 205-211, issn 0344-5704, 7 p.Article

Hand-Foot Syndrome With Sclerodactyly-Like Changes in a Patient Treated With CapecitabineTRINDADE, Felicidade; HARO, Rosario; FARINA, Maria Carmen et al.The American journal of dermatopathology. 2008, Vol 30, Num 2, pp 172-173, issn 0193-1091, 2 p.Article

Dose escalation study on oxaliplatin and Capecitabine (Xeloda) in patients with advanced solid tumorsKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2004, Vol 66, Num 4, pp 253-259, issn 0030-2414, 7 p.Article

Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adultsPATEL, Aneeta; PLUIM, Thomas; HELMS, Amy et al.Cancer chemotherapy and pharmacology. 2004, Vol 53, Num 5, pp 409-414, issn 0344-5704, 6 p.Article

Inappropriate continuation of medication when patients are admitted acutely: the example of capecitabineBOOTH, J. A; BOOTH, C; CRAWFORD, S. Michael et al.Clinical medicine. 2011, Vol 11, Num 5, issn 1470-2118, p. 511Article

Phase IB Study of the mTOR Inhibitor Ridaforolimus With CapecitabinePEROTTI, Antonella; LOCATELLI, Alberta; ALBANELL, Joan et al.Journal of clinical oncology. 2010, Vol 28, Num 30, pp 4554-4561, issn 0732-183X, 8 p.Article

Solubility of capecitabine and docetaxel in supercritical carbon dioxide: Data and the best correlationYAMINI, Yadollah; HOJJATI, Mohammad; KALANTARIAN, Pardis et al.Thermochimica acta. 2012, Vol 549, pp 95-101, issn 0040-6031, 7 p.Article

Synthesis and biological activity evaluation of cytidine-5'-deoxy-5-fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2',3'-carbonatesJHANSI RANI, V; RAGHAVENDRA, A; KISHORE, P et al.European journal of medicinal chemistry. 2012, Vol 54, pp 690-696, issn 0223-5234, 7 p.Article

Stability studies of capecitabineLASZCZ, M; TRZCINSKA, K; FILIP, K et al.Journal of thermal analysis and calorimetry. 2011, Vol 105, Num 3, pp 1015-1021, issn 1388-6150, 7 p.Article

Weekday on-weekend off oral capecitabine : a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapyPENTHEROUDAKIS, G; PAPPAS, P; MARSELOS, M et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 5, pp 733-739, issn 0344-5704, 7 p.Article